Interview: Lee-Cheng Liu, President & CEO, EirGenix, Taiwan
Dr. Liu, President and CEO of EirGenix, talks about why he sees Taiwan as the ideal market for a CDMO like Eirgenix, why he believes that despite the skepticism, biosimilars…
EY is a global leader in professional services, employing 167,000 people in 150 countries and 728 offices around the globe. Their global revenues amounted to US$24.4 billion in financial year 2012. Apart from auditing services, EY also provides advisory services including tax advisory, transaction advisory, internal control, risk management, information technology security, performance improvement and corporate governance, etc. They are recognized for “delivering value” to their clients in different service areas. In 2012, they provided audit, risk management, tax and other advisory services to 80 percent and 63 percent of Fortune Global 500 and Forbes Global 2000 companies, respectively. Their strategy is to use their global professional talent and knowledge to assist their clients to tackle challenges in an ever-changing market environment.
EY Taiwan was established as the first partnership accounting firm in Taiwan, and is an official member of EY. They employ 1,200 professionals across Taiwan by creating the right team in the right place, and provide clients with multi-disciplinary assurance, business advisory, tax and transaction advisory services. Their main office is located in Taipei, with five branch offices in Chungli, Hsinchu, Taichung, Tainan, and Kaohsiung. They have joined EY in China and Hong Kong in forming the Greater China Area to provide clients with comprehensive and efficient services by leveraging their knowledge base and integrated network.
Contact details
Assurance
Based on legitimate professional standards, their assurance, financial report audit, and other value added services assist companies to improve effectiveness and quality.
Assurance Services Leader: Kim Chang / +886-2-2757-8888 #2317
Tax
They help companies navigate the latest tax policies, provide tax assessment and diagnosis, and address potential tax risks.
Tax Services Leader: Heidi Liu / 886-2-2757-8888 #2705
Transactions
They assist clients to evaluate, negotiate, structure, and succeed in transactions by seizing market opportunities to sustain advantageous position and boost growth.
Transaction Advisory Services Managing Director: Jonathan Hsin / +886-2-2757-8888 #1527
Advisory
When major issues strike, their approach helps organizations reduce risks, improve performance, overcome the internal and external challenges, and maximize profits.
Advisory Services Managing Director: Tony Chang / +886-2-2757-8888 #1563
Entrepreneurship
They celebrate entrepreneurs who lead the companies to embed innovation and embrace growth honoring their visions, leaderships, and extraordinary achievements. They present Taiwan entrepreneurship to the world through EY’s global network.
Ernst & Young Foundation / +886-2-2757-8888
Dr. Liu, President and CEO of EirGenix, talks about why he sees Taiwan as the ideal market for a CDMO like Eirgenix, why he believes that despite the skepticism, biosimilars…
Whaijen Soo, Managing Director of Supra Integration and Incubation Center (Si2C) speaks about Taiwan’s biotech industry, emphasizing the need for risk tolerance and understanding investing rationale in propelling Taiwan’s industry…
Audrey Tseng, Deputy Chairman of PwC Taiwan with PwC Partners Lily Wong and Andy Chang, delve into factors behind the booming pharma and biotech industry in Taiwan, how to prevent…
Dr Yu-Ray Chen, Professor of Surgery at Chang Gung Memorial Hospital discusses the current state of Taiwan’s healthcare system, highlighting the fact that its current condition is unsustainable in the…
Michael Chiang, the Executive President of Panion & BF Biotech speaks about the incredible growth of the company over the past year, what has contributed to this success and where…
James Wang, Country Managing Partner of Ernst & Young Taiwan explains why Taiwan’s DIG (Diversify-Innovative-Globalize) strategy is crucial for the growth of Taiwan’s economy over the next decade, why biotech…
Full service CRO Choice Pharma moved its operations from Europe to Asia in 2008, and since then the company has thrived. The managing director and business director for the company…
A 2006 article in CommonWealth Magazine detailing the genesis of this company reported that TLC had managed to “break out from the typical dilemma of ordinary biotech firms—to either engage…
The president of Pharmaceutical Industry Technology and Development Center (PITDC) considers the company’s need to remain an international competitor and how to achieve it, the gap in new drug development…
General Manager, Chugai Pharma Taiwan and President of International Research-Based Pharmaceutical Manufacturers’ Association (IRPMA), discusses the continuous price cuts that plague the Taiwan market, and how IRPMA is getting involved…
The CEO of ASLAN Pharmaceuticals discusses the fundamental changes that need to occur in the treatment of serious illnesses, the advantages of building a second branch in Taiwan, and the…
The chairman of Taipei Medical University (TMU) discusses the key challenges TMU has faced over the years, how these challenges will continue to affect the future, and what international accreditation…
See our Cookie Privacy Policy Here